Pre-order Enquiry
Request Free Sample
Global On-body Injectors Market Professional Survey Report 2019
SKU ID : QYR-14658992 | Publishing Date : 06-Sep-2019 | No. of pages : 134
An on-body Injector is a small, lightweight delivery system applied to the skin.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
The global On-body Injectors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on On-body Injectors volume and value at global level, regional level and company level. From a global perspective, this report represents overall On-body Injectors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of On-body Injectors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their On-body Injectors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Electronical Injectors
Mechanical Injectors
Others
Segment by Application
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
The global On-body Injectors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on On-body Injectors volume and value at global level, regional level and company level. From a global perspective, this report represents overall On-body Injectors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of On-body Injectors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their On-body Injectors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Electronical Injectors
Mechanical Injectors
Others
Segment by Application
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
